Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

NCT01453998 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

657

Enrollment

INDUSTRY

Sponsor class

Conditions

Acellular Pertussis
Hepatitis B
Haemophilus Influenzae Type b
Tetanus
Diphtheria
Poliomyelitis

Interventions

BIOLOGICAL: Infanrix hexa
BIOLOGICAL: Prevenar 13
BIOLOGICAL: GSK217744

Sponsor

GlaxoSmithKline